Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa

Infection. 2016 Apr;44(2):259-62. doi: 10.1007/s15010-015-0821-7. Epub 2015 Jul 14.

Abstract

Introduction: We report an unusual case of acute acquired toxoplasmosis (AAT) presenting as lymphadenopathy and recurrent seizures in an immunocompetent 15-year-old boy.

Materials and methods: The patient reported an 18-day vacation to Africa (Ethiopia), 39 days prior to the first seizure. Electroencephalogram (EEG) showed sporadic single-spike or sharp-wave paroxysms and the magnetic resonance imaging (RMI) of the brain was negative. The serology for T. gondii was compatible with an acute infection defined as positive for both toxoplasma-specific IgG and IgM and a low avidity (6 %), confirmed by a reference laboratory. The patient reported other two episodes of seizures, occurring 7 days apart. He was treated with pyrimethamine plus sulfadiazine and leucovorin for 4 weeks, with an improvement of lymphadenitis and normalization of EEG. After 5 months, new seizures were reported and a diagnosis of epilepsy was done. Toxoplasma polymerase chain reaction (PCR) of cerebrospinal fluid (CSF) and blood were negative. A treatment with valproic acid was started, obtaining control of the neurological disease.

Conclusion: Awareness of this neurologic manifestation by clinicians is required, also in immunocompetent patients. The relationship between toxoplasmosis and recurrent seizure needs to be investigated by new studies.

Keywords: Acute acquired toxoplasmosis; Immunocompetent; Seizure; Toxoplasma gondii; Travel.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibodies, Protozoan / blood
  • Anticonvulsants / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Epilepsy / complications
  • Epilepsy / diagnosis*
  • Epilepsy / pathology
  • Ethiopia
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Leucovorin / therapeutic use
  • Male
  • Pyrimethamine / therapeutic use
  • Recurrence
  • Seizures / diagnosis*
  • Seizures / pathology
  • Sulfadiazine / therapeutic use
  • Toxoplasma / immunology
  • Toxoplasmosis / complications*
  • Toxoplasmosis / diagnosis*
  • Toxoplasmosis / pathology
  • Travel*
  • Treatment Outcome
  • Valproic Acid / therapeutic use

Substances

  • Antibodies, Protozoan
  • Anticonvulsants
  • Antiprotozoal Agents
  • Immunoglobulin G
  • Immunoglobulin M
  • Sulfadiazine
  • Valproic Acid
  • Leucovorin
  • Pyrimethamine